123 related articles for article (PubMed ID: 29394494)
21. Regulation of TNF mediated antiapoptotic signaling in human neutrophils: role of delta-PKC and ERK1/2.
Kilpatrick LE; Sun S; Mackie D; Baik F; Li H; Korchak HM
J Leukoc Biol; 2006 Dec; 80(6):1512-21. PubMed ID: 17138860
[TBL] [Abstract][Full Text] [Related]
22. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
Mhaidat NM; Zhang XD; Jiang CC; Hersey P
Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
[TBL] [Abstract][Full Text] [Related]
23. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
[TBL] [Abstract][Full Text] [Related]
24. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M
Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478
[TBL] [Abstract][Full Text] [Related]
25. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
26. Quercetin attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways.
Li C; Wang T; Zhang C; Xuan J; Su C; Wang Y
Gene; 2016 Feb; 577(2):275-80. PubMed ID: 26680104
[TBL] [Abstract][Full Text] [Related]
27. Quercetin suppresses the proliferation of multiple myeloma cells by down-regulating IQ motif-containing GTPase activating protein 1 expression and extracellular signal-regulated kinase activation.
Ma Y; Jin Z; Huang J; Zhou S; Ye H; Jiang S; Yu K
Leuk Lymphoma; 2014 Nov; 55(11):2597-604. PubMed ID: 24397597
[TBL] [Abstract][Full Text] [Related]
28. Diallyl disulphide inhibits apolipoprotein(a) expression in HepG2 cells through the MEK1-ERK1/2-ELK-1 pathway.
Ma X; Liu Y; Tan Y; Qu K; He X; Zhang H; Wang Z
Lipids Health Dis; 2017 Nov; 16(1):223. PubMed ID: 29178936
[TBL] [Abstract][Full Text] [Related]
29. p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-alpha induced endothelial apoptosis.
Grethe S; Pörn-Ares MI
Cell Signal; 2006 Apr; 18(4):531-40. PubMed ID: 15972258
[TBL] [Abstract][Full Text] [Related]
30. Liposome-mediated RNA interference delivery against Erk1 and Erk2 does not equally promote chemosensitivity in human hepatocellular carcinoma cell line HepG2.
Mehdizadeh A; Somi MH; Darabi M; Farajnia S; Akbarzadeh A; Montazersaheb S; Yousefi M; Bonyadi M
Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1612-1619. PubMed ID: 28058860
[TBL] [Abstract][Full Text] [Related]
31. MAPK signaling pathways regulate mitochondrial-mediated apoptosis induced by isoorientin in human hepatoblastoma cancer cells.
Yuan L; Wang J; Xiao H; Wu W; Wang Y; Liu X
Food Chem Toxicol; 2013 Mar; 53():62-8. PubMed ID: 23220614
[TBL] [Abstract][Full Text] [Related]
32. Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy.
Mandal R; Becker S; Strebhardt K
Oncogene; 2016 May; 35(20):2547-61. PubMed ID: 26364606
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
34. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways.
Kamiguti AS; Harris RJ; Slupsky JR; Baker PK; Cawley JC; Zuzel M
Oncogene; 2003 Apr; 22(15):2272-84. PubMed ID: 12700663
[TBL] [Abstract][Full Text] [Related]
35. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
Wang JG; Zheng XX; Zeng GY; Zhou YJ; Yuan H
Oncol Rep; 2014 Jan; 31(1):488-96. PubMed ID: 24247909
[TBL] [Abstract][Full Text] [Related]
36. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis.
Huynh H; Nguyen TT; Chow KH; Tan PH; Soo KC; Tran E
BMC Gastroenterol; 2003 Aug; 3():19. PubMed ID: 12906713
[TBL] [Abstract][Full Text] [Related]
37. Activation of ERK and p38 Reduces AZD8055-Mediated Inhibition of Protein Synthesis in Hepatocellular Carcinoma HepG2 Cell Line.
Jee HY; Lee YG; Lee S; Elvira R; Seo HE; Lee JY; Han J; Lee K
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769253
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effect of Quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways.
Liu H; Zhou M
BMC Complement Altern Med; 2017 Dec; 17(1):531. PubMed ID: 29237430
[TBL] [Abstract][Full Text] [Related]
39. Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells.
Liu HF; Hu HC; Chao JI
Chem Biol Interact; 2010 Dec; 188(3):535-45. PubMed ID: 20708607
[TBL] [Abstract][Full Text] [Related]
40. [Effects of P2Y receptor activation on prostatic cancer cells requiring ERK1/2 or p38 cascade].
Chen L; Fang WG; Heng WJ; You JF
Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):146-50. PubMed ID: 15132853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]